ArticleIndian pediatrics2026
Diagnostic Accuracy of Pro-Brain Natriuretic Peptide and N-Terminal-Pro-Brain Natriuretic Peptide in Diagnosing Incomplete Kawasaki Disease.
Article in Indian pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo study the diagnostic performance of pro-brain natriuretic peptide (Pro-BNP) and N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) levels in diagnosing Kawasaki disease (KD), including incomplete forms, in a developing country setting.
methodsIn this cross-sectional study, levels of Pro-BNP and NT-pro-BNP were compared between 37 cases with KD, as defined by American Heart Association and 37 controls (age- and gender-matched children with acute febrile illness). Echocardiogram and biochemical estimation of the above markers were performed in children with KD before administration of intravenous immunoglobulin. The same markers were estimated in controls at diagnosis. Receiver operating curve (ROC) was plotted to derive diagnostic cutoff of biomarkers in children with KD.
resultsThe median (IQR) age of the study population was 30 (18, 48) months. Incomplete KD was observed in 17 (46%) children. The most common illness in controls was scrub typhus (n = 11; 27%). Seventeen (46%) children with KD had coronary artery aneurysm. Levels of biomarkers were higher in cases compared to controls [Pro-BNP: 4690 (3579, 5726) vs 475 (72, 666) pg/mL, P < 0.001; and NT-pro-BNP: 901 (802, 1037) vs. 84 (25,97) pg/mL, P < 0.001)]. A cutoff of 2899 pg/mL for Pro-BNP and 339 pg/mL for NT-pro-BNP predicted the diagnosis of KD. Subgroup analysis in 54 children with fever showed false positivity rate of 27% with AHA criteria that reduced to 3% with the addition of Pro-BNP or NT-pro-BNP.
conclusionsThe levels of Pro-BNP and NT-pro-BNP were significantly higher in children with KD than children with acute febrile illness and had a good diagnostic accuracy for KD.
Indexed as
Identifiers
41081993What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.